Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Pediatric Surgery International
Erschienen in: Pediatric Surgery International 6/2010

01.06.2010 | Review Article

Tissue engineering and regenerative medicine research perspectives for pediatric surgery

verfasst von: Amulya K. Saxena

Erschienen in: Pediatric Surgery International | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Tissue engineering and regenerative medicine research is being aggressively pursued in attempts to develop biological substitutes to replace lost tissue or organs. Remarkable degrees of success have been achieved in the generation of a variety of tissues and organs as a result of concerted contributions by multidisciplinary groups in the field of biotechnology. Engineering of an organ is a complex process which is initiated by appropriate sourcing of cells and their controlled proliferation to achieve critical numbers for seeding on biodegradable scaffolds in order to create cell-scaffold constructs, which are thereafter maintained in bioreactors to generate tissues identical to those required for replacement. Extensive efforts in understanding the characteristics of cells and their interaction with specifically tailored scaffolds holds the key to their attachment, controlled proliferation and differentiation, intercommunication, and organization to form tissues. The demand for tissue-engineered organs is enormous and this technology holds the promise to supply customized organs to overcome the severe shortages that are currently faced by the pediatric patient, especially due to organ-size mismatch. The contemporary state of tissue-engineering technology presented in this review summarizes the advances in the various areas of regenerative medicine and addresses issues that are associated with its future implementation in the pediatric surgical patient.
Literatur
1.
2.
Lysaght MJ, O’Loughlin JA (2000) Demographic scope and economic magnitude of contemporary organ replacement therapies. ASAIO J 46:515–521PubMedCrossRef
3.
Eurotransplant International Foundation Annual Report 2008. In: Oosterlee A, Rahmel A (eds) Eurotransplant International Foundation, Leiden, The Netherlands. ISBN-13: 978-90-71658-28-0
4.
2008 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1998–2007. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD
5.
Giovanelli M, Gupte GL, McKiernan P et al (2009) Impact of change in the United Kingdom pediatric donor organ allocation policy for intestinal transplantation. Transplantation 87:1695–1699PubMedCrossRef
6.
Tiao GM, Alonso MH, Ryckman FC (2006) Pediatric liver transplantation. Semin Pediatr Surg 15:218–227PubMedCrossRef
7.
Harada KM, Mandia-Sampaio EL, de Sandes-Freitas TV et al (2009) Risk factors associated with graft loss and patient survival after kidney transplantation. Transplant Proc 41:3667–3670PubMedCrossRef
8.
Reding R (2005) Long-term complications of immunosuppression in pediatric liver recipients. Acta Gastroenterol Belg 68:453–456PubMed
9.
Magee JC, Krishnan SM, Benfield MR (2008) Pediatric transplantation in the United States, 1997–2006. Am J Transplant 8:935–945PubMedCrossRef
10.
Golomb J, Klutke CG, Lewin KJ et al (1989) Bladder neoplasms associated with augmentation cystoplasty: report of 2 cases and literature review. J Urol 142:377–380PubMed
11.
Castagna MT, Mintz GS, Ohlmann P et al (2005) Incidence, location, magnitude, and clinical correlates of saphenous vein graft calcification: an intravascular ultrasound and angiographic study. Circulation 111:1148–1152PubMedCrossRef
12.
13.
Jaffe R, Strauss BH (2007) Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives. J Am Coll Cardiol 50:119–127PubMedCrossRef
14.
Guyen O, Lewallen DG, Cabanela ME (2008) Modes of failure of osteonics constrained tripolar implants: a retrospective analysis of forty-three failed implants. J Bone Joint Surg Am 90:1553–1560PubMedCrossRef
15.
Yukata K, Doi K, Hattori Y et al (2009) Early breakage of a titanium volar locking plate for fixation of a distal radius fracture: case report. J Hand Surg Am 34:907–909PubMedCrossRef
16.
Schildhauer TA, Robie B, Muhr G et al (2006) Bacterial adherence to tantalum versus commonly used orthopedic metallic implant materials. J Orthop Trauma 20:476–484PubMedCrossRef
17.
Jeandidier N, Riveline JP, Tubiana-Rufi N et al (2008) Treatment of diabetes mellitus using an external insulin pump in clinical practice. Diabetes Metab 34:425–438PubMedCrossRef
18.
Piaggesi A (2004) Research development in the pathogenesis of neuropathic diabetic foot ulceration. Curr Diab Rep 4:419–423PubMedCrossRef
19.
Senker J, Enzing C, Joly PB et al (2000) European exploitation of biotechnology-do government policies help? A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector. Nat Biotechnol 18:605–608PubMedCrossRef
20.
Tabata Y (2009) Biomaterial technology for tissue engineering applications. J R Soc Interface 6(Suppl 3):S311–S324PubMedCrossRef
21.
22.
Burdick JA, Vunjak-Novakovic G. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A 15:205–219
23.
Carrel A, Lindbergh C (1938) The culture of organs. Paul B. Hoeber Inc., Harper Brothers, New York
24.
25.
26.
Thomson JA et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147PubMedCrossRef
27.
28.
29.
Amit M, Carpenter MK, Inokuma MS et al (2000) Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227:271–278PubMedCrossRef
30.
Odorico JS, Kaufman DS, Thomson JA (2001) Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19:193–204PubMedCrossRef
31.
Cowan CA, Klimanskaya I, McMahon J et al (2004) Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350:1353–1356PubMedCrossRef
32.
Schuldiner M, Itskovitz-Eldor J, Benvenisty N (2003) Selective ablation of human embryonic stem cells expressing a “suicide” gene. Stem Cells 21:257–265PubMedCrossRef
33.
Drukker M, Katz G, Urbach A et al (2002) Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 99:9864–9869PubMedCrossRef
34.
35.
Hall VJ, Stojkovic P, Stojkovic M (2006) Using therapeutic cloning to fight human disease: a conundrum or reality? Stem Cells 24:1628–1637PubMedCrossRef
36.
Colman A, Kind A (2000) Therapeutic cloning: concepts and practicalities. Trends Biotechnol 18:192–196PubMedCrossRef
37.
Priddle H, Jones DR, Burridge PW et al (2006) Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies. Stem Cells 24:815–824PubMedCrossRef
38.
Raikwar SP, Mueller T, Zavazava N (2006) Strategies for developing therapeutic application of human embryonic stem cells. Physiology (Bethesda) 21:19–28
39.
Tian X, Kaufman DS (2005) Hematopoietic development of human embryonic stem cells in culture. Methods Mol Med 105:425–436PubMed
40.
Trounson A (2006) The production and directed differentiation of human embryonic stem cells. Endocr Rev 27:208–219PubMedCrossRef
41.
Leker RR, McKay RD (2004) Using endogenous neural stem cells to enhance recovery from ischemic brain injury. Curr Neurovasc Res 1:421–427PubMedCrossRef
42.
Beltrami AP, Barlucchi L, Torella D et al (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763–776PubMedCrossRef
43.
Kuroda R, Usas A, Kubo S et al (2006) Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 54:433–442PubMedCrossRef
44.
45.
Zalzman M, Anker-Kitai L, Efrat S (2005) Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype. Diabetes 54:2568–2575PubMedCrossRef
46.
Raghunath J, Salacinski HJ, Sales KM et al (2005) Advancing cartilage tissue engineering: the application of stem cell technology. Curr Opin Biotechnol 16:503–509PubMedCrossRef
47.
Riha GM, Lin PH, Lumsden AB, Yao Q (2005) Review: application of stem cells for vascular tissue engineering. Tissue Eng 11:1535–1552PubMedCrossRef
48.
Risbud MV, Shapiro IM (2005) Stem cells in craniofacial and dental tissue engineering. Orthod Craniofac Res 8:54–59PubMed
49.
Bruder SP, Fink DJ, Caplan AI (1994) Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56:283–294PubMedCrossRef
50.
Gimble J, Guilak F (2003) Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5:362–369PubMedCrossRef
51.
De Coppi P, Bartsch G, Siddiqui MM et al (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100–106PubMedCrossRef
52.
Miki T, Lehmann T, Cai H et al (2005) Stem cell characteristics of amniotic epithelial cells. Stem Cells 23:1549–1559PubMedCrossRef
53.
Saxena AK (2005) Tissue engineering: present concepts and strategies. J Indian Assoc Pediatr Surg 10:14–19CrossRef
54.
Langer R, Tirrell DA (2004) Designing materials for biology and medicine. Nature 428:487–492PubMedCrossRef
55.
Boccaccini AR, Blaker JJ (2005) Bioactive composite materials for tissue engineering scaffolds. Expert Rev Med Devices 2:303–317PubMedCrossRef
56.
Behonick DJ, Werb Z (2003) A bit of give and take: the relationship between the extracellular matrix and the developing chondrocyte. Mech Dev 120:1327–1336PubMedCrossRef
57.
Ma Z, He W, Yong T et al (2005) Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell orientation. Tissue Eng 11:1149–1158PubMedCrossRef
58.
Rho KS, Jeong L, Lee G et al (2006) Electrospinning of collagen nanofibers: effects on the behavior of normal human keratinocytes and early-stage wound healing. Biomaterials 27:1452–1461PubMedCrossRef
59.
Ayutsede J, Gandhi M, Sukigara S et al (2006) Carbon nanotube-reinforced Bombyx morisilk nanofibers by the electrospinning process. Biomacromolecules 7:208–224PubMedCrossRef
60.
Stankus JJ, Guan J, Fujimoto K et al (2006) Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials 27:735–744PubMedCrossRef
61.
62.
Nguyen KT, West JL (2002) Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 23:4307–4314PubMedCrossRef
63.
Lutolf MP, Hubbell JA (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23:47–55PubMedCrossRef
64.
Tibbitt MW, Anseth KS (2009) Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 103:655–663PubMedCrossRef
65.
Grayson WL, Zhao F, Izadpanah R et al (2006) Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol 207:331–339PubMedCrossRef
66.
Niklason LE, Gao J, Abbott WM et al (1999) Functional arteries grown in vitro. Science 284:489–493PubMedCrossRef
67.
Barron V, Lyons E, Stenson-Cox C et al (2003) Bioreactors for cardiovascular cell and tissue growth: a review. Ann Biomed Eng 31:1017–1030PubMedCrossRef
68.
Eschenhagen T, Fink C, Remmers U et al (1997) Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart model system. FASEB J 11:683–694PubMed
69.
Carrier RL, Papadaki M, Rupnick M et al (1999) Cardiac tissue engineering: cell seeding, cultivation parameters and tissue construct characterization. Biotechnol Bioeng 64:580–589PubMedCrossRef
70.
Zimmermann WH, Melnychenko I, Wasmeier G et al (2006) Engineered heart tissue grafts improve systolic and diastolic function in infracted rat hearts. Nat Med 12:452–458PubMedCrossRef
71.
Guo XM, Zhao YS, Chang HX et al (2006) Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation 113:2229–2237PubMedCrossRef
72.
Shimizu T, Yamato M, Isoi Y et al (2002) Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Cir Res 90:e40–e48CrossRef
73.
Guo Y, Zhang XZ, Wei Y et al (2009) Culturing of ventricle cells at high density and construction of engineered cardiac cell sheets without scaffold. Int Heart J 50:653–662PubMedCrossRef
74.
Shinoka T, Ma PX, Shum-Tim D et al (1996) Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 94(Suppl 9):II164–II168
75.
Schnell AM, Hoerstrup SP, Zund G et al (2001) Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts. Thorac Cardiovasc Surg 49:221–225PubMedCrossRef
76.
Sutherland FWH, Perry TE, Nasseri BA et al (2002) Advances in the mechanisms of cell delivery to cardiovascular scaffolds: comparison of two rotating cell culture systems. ASAIO J 48:346–349PubMedCrossRef
77.
Engelmayr GC, Hildebrand DK, Sutherland FW et al (2003) A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart-valve biomaterials. Biomaterials 24:2523–2532PubMedCrossRef
78.
Dohmen PM, Lembcke A, Hotz H et al (2002) Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 74:1438–1442PubMedCrossRef
79.
Dohmen PM, Lembcke A, Holinski S et al (2007) Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg 84:729–736PubMedCrossRef
80.
Shinoka T, Breuer C (2008) Tissue-engineered blood vessels in pediatric cardiac surgery. Yale J Biol Med 81:161–166PubMed
81.
Narushima M, Kobayashi N, Okitsu T et al (2005) A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 23:1274–1282PubMedCrossRef
82.
Yanagita M, Nakayama K, Takeuchi T (1992) Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the nonendocrine cell line, COS-7. FEBS Lett 311:55–59PubMedCrossRef
83.
84.
Jun HS, Yoon JW (2005) Approaches for the cure of type 1 diabetes by cellular and gene therapy. Curr Gene Ther 5:249–262PubMedCrossRef
85.
Mikos A, Papadaki M, Kouvroukoglou S et al (1994) Mini-review: islet transplantation to create a bioartificial pancreas. Biotechnol Bioeng 43:673–677PubMedCrossRef
86.
Soon-Shiong P, Heintz RE, Merideth N et al (1994) Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343:950–951PubMedCrossRef
87.
Calafiore R, Basta G, Luca G et al (2006) Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 29:137–138PubMedCrossRef
88.
Tuch BE, Keogh GW, Williams LJ et al (2009) Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 32:1887–1889PubMedCrossRef
89.
Takimoto Y, Okumura N, Nakamura T et al (1993) Long-term follow-up of the experimental replacement of the esophagus with a collagen–silicone composite tube. ASAIO J 39:M736–M739PubMedCrossRef
90.
Yamamoto Y, Nakamura T, Shimizu Y et al (1999) Intrathoracic esophageal replacement in the dog with the use of an artificial esophagus composed of a collagen sponge with a double-layered silicone tube. J Thorac Cardiovasc Surg 118:276–286PubMedCrossRef
91.
Yamamoto Y, Nakamura T, Shimizu Y et al (2000) Intrathoracic esophageal replacement with a collagen sponge–silicone double-layer tube: evaluation of omental-pedicle wrapping and prolonged placement of an inner stent. ASAIO J 46:734–739PubMedCrossRef
92.
Hori Y, Nakamura T, Kimura D et al (2003) Effect of basic fibroblast growth factor on vascularization in esophagus tissue engineering. Int J Artif Organs 26:241–244PubMed
93.
Sato M, Ando N, Ozawa S et al (1994) An artificial esophagus consisting of cultured human esophageal epithelial cells, polyglycolic acid mesh, and collagen. ASAIO J 40:M389–M392PubMedCrossRef
94.
Hayashi K, Ando N, Ozawa S et al (2004) A neo-esophagus reconstructed by cultured human esophageal epithelial cells, smooth muscle cells, fibroblasts, and collagen. ASAIO J 50:261–266PubMedCrossRef
95.
Badylak S, Meurling S, Chen M et al (2000) Resorbable bioscaffold for esophageal repair in a dog model. J Pediatr Surg 35:1097–1103PubMedCrossRef
96.
Badylak SF, Vorp DA, Spievack AR et al (2005) Esophageal reconstruction with ECM and muscle tissue in a dog model. J Surg Res 128:87–97PubMed
97.
Doede T, Bondartschuk M, Joerck C et al (2009) Unsuccessful alloplastic esophageal replacement with porcine small intestinal submucosa. Artif Organs 33:328–333PubMedCrossRef
98.
Nakase Y, Nakamura T, Kin S et al (2008) Intrathoracic esophageal replacement by in situ tissue-engineered esophagus. J Thorac Cardiovasc Surg 136:850–859PubMedCrossRef
99.
Grikscheit T, Ochoa ER, Srinivasan A et al (2003) Tissue-engineered esophagus: experimental substitution by onlay patch or interposition. J Thorac Cardiovasc Surg 126:537–544PubMedCrossRef
100.
Saxena AK, Ainoedhofer H, Höllwarth ME (2009) Esophagus tissue engineering: in vitro generation of esophageal epithelial cell sheets and viability on scaffold. J Pediatr Surg 44:896–901PubMedCrossRef
101.
Saxena AK, Kofler K, Ainödhofer H et al (2009) Esophagus tissue engineering: hybrid approach with esophageal epithelium and unidirectional smooth muscle tissue component generation in vitro. J Gastrointest Surg 13:1037–1043PubMedCrossRef
102.
Soltysiak P, Saxena AK (2009) Micro-computed tomography for implantation site imaging during in situ oesophagus tissue engineering in a live small animal model. J Tissue Eng Regen Med 3:573–576PubMedCrossRef
103.
Saxena AK, Ainoedhofer H, Höllwarth ME (2010) Culture of ovine esophageal epithelial cells and in vitro esophagus tissue engineering. Tissue Eng Part C Methods 16:109–114
104.
Kofler K, Ainoedhofer H, Höllwarth ME et al (2010) Fluorescence-activated cell sorting of PCK-26 antigen-positive cells enables selection of ovine esophageal epithelial cells with improved viability on scaffolds for esophagus tissue engineering. Pediatr Surg Int 26:97–104PubMedCrossRef
105.
Saxena AK, Soltysiak P, Ainoedhofer H (2009) Esophagus tissue engineering: In situ generation of vascularized esophageal conduits using the ovine model. Abstracts of the 41st Annual Meeting of the Canadian Association of Pediatric Surgeons, Oct 1–4, Halifax, Nova Scotia, Canada
106.
Vacanti JP, Morse MA, Saltzman WM et al (1998) Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 23:3–9CrossRef
107.
Patel HR, Tait IS, Evans GS et al (1996) Influence of cell interactions in a novel model of postnatal mucosal regeneration. Gut 38:679–686PubMedCrossRef
108.
Evans GS, Flint N, Somers AS et al (1992) The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci 101:219–231PubMed
109.
Tait IS, Flint N, Campbell FC et al (1994) Generation of neomucosa in vivo by transplantation of dissociated rat postnatal small-intestinal epithelium. Differentiation 56:91–100PubMed
110.
Tait IS, Evans GS, Flint N et al (1994) Colonic mucosal replacement by syngeneic small intestinal stem cell transplantation. Am J Surg 167:67–72PubMedCrossRef
111.
Choi RS, Riegler M, Pothoulakis C et al (1998) Studies of brush border enzymes, basement membrane components, and electrophysiology of tissue-engineered neointestine. J Pediatr Surg 33:991–996PubMedCrossRef
112.
Kim SS, Kaihara S, Benvenuto MS et al (1999) Effects of anastomosis of tissue engineered neointestine to native small bowel. J Surg Res 87:6–13PubMedCrossRef
113.
Grikscheit TC, Siddique A, Ochoa ER et al (2004) Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 240:748–754PubMedCrossRef
114.
Lloyd DA, Ansari TI, Gundabolu P et al (2006) A pilot study investigating a novel subcutaneously implanted precellularized scaffold for tissue engineering of intestinal mucosa. Eur Cell Mater 11:27–33PubMed
115.
Sala FG, Kunisaki SM, Ochoa ER et al (2009) Tissue-engineered small intestine and stomach form from autologous tissue in a preclinical large animal model. J Surg Res 156:205–212PubMedCrossRef
116.
Nony PA, Schnellmann RG (2003) Mechanisms of renal cell repair and regeneration after acute renal failure. J Pharmacol Exp Ther 304:905–912PubMedCrossRef
117.
118.
Oliver JA, Maarouf O, Cheema FH et al (2004) The renal papilla is a niche for adult kidney stem cells. J Clin Invest 114:795–804PubMed
119.
Duffield JS, Park KM, Hsiao LL et al (2005) Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115:1743–1755PubMedCrossRef
120.
Lin F, Moran A, Igarashi P (2005) Intrarenal cells, not bone marrow–derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 115:1756–1764PubMedCrossRef
121.
Brodie JC, Humes HD (2005) Stem cell approaches for the treatment of renal failure. Pharmacol Rev 57:299–313PubMedCrossRef
122.
Steenhard BM, Isom KS, Cazcarro P et al (2005) Integration of embryonic stem cells in metanephric kidney organ culture. J Am Soc Nephrol 16:1623–1631PubMedCrossRef
123.
Wang PC, Takezawa T (2005) Reconstruction of renal glomerular tissue using collagen vitrigel scaffold. J Biosci Bioeng 99:529–540PubMedCrossRef
124.
Joraku A, Stern KA, Atala A et al (2009) In vitro generation of three-dimensional renal structures. Methods 47:129–133PubMedCrossRef
125.
Roessger A, Denk L, Minuth WW (2009) Potential of stem/progenitor cell cultures within polyester fleeces to regenerate renal tubules. Biomaterials 30:3723–3732PubMedCrossRef
126.
Kropp BP, Cheng EY, Lin HK et al (2004) Reliable and reproducible bladder regeneration using unseeded distal small intestinal ubmucosa. J Urol 172:1710–1713PubMedCrossRef
127.
Yoo JJ, Meng J, Oberpenning F et al (1998) Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology 51:221–225PubMedCrossRef
128.
Probst M, Dahiya R, Carrier S et al (1997) Reproduction of functional smooth muscle tissue and partial bladder replacement. Br J Urol 79:505–515PubMed
129.
Portis AJ, Elbahnasy AM, Shalhav AL et al (2000) Laparoscopic augmentation cystoplasty with different biodegradable grafts in an animal model. J Urol 164:1405–1411PubMedCrossRef
130.
Landman J, Olweny E, Sundaram CP et al (2004) Laparoscopic mid-sagittal hemicystectomy and bladder reconstruction with small intestinal submucosa and reimplantation of ureter into small intestinal submucosa: 1-year follow-up. J Urol 171:2450–2455PubMedCrossRef
131.
Oberpenning FO, Meng J, Yoo J et al (1999) De novo reconstitution of a functional urinary bladder by tissue engineering. Nat Biotechnol 17:149–155PubMedCrossRef
132.
Atala A, Bauer SB, Soker S et al (2006) Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367:1241–1246PubMedCrossRef
133.
Soler R, Fullhase C, Atala A et al (2009) Regenerative medicine strategies for treatment of neurogenic bladder. Therapy 6:177–184PubMedCrossRef
134.
Guillouzo A (1998) Liver cell models in in vitro toxicology. Environ Health Perspect 106:511–532PubMedCrossRef
135.
Mitaka T (1998) The current status of primary hepatocyte culture. Int J Exp Pathol 79:393–409PubMedCrossRef
136.
Ranucci CS, Kumar A, Batra SP et al (2000) Control of hepatocyte function on collagen foams: sizing matrix pores toward selective induction of 2D and 3D cellular morphogenesis. Biomaterials 21:783–793PubMedCrossRef
137.
Seo SJ, Choi YJ, Akaike T et al (2006) Alginate/galactosylated chitosan/heparin scaffold as a new synthetic extracellular matrix for hepatocytes. Tissue Eng 12:33–44PubMedCrossRef
138.
Tan W, Desai TA (2003) Microfluidic patterning of cells in extracellular matrix biopolymers: effects of channel size, cell type, and matrix composition on pattern integrity. Tissue Eng 9:255–267PubMedCrossRef
139.
Wang X, Yan Y, Pan Y et al (2006) Generation of three-dimensional hepatocyte/gelatin structures with rapid prototyping system. Tissue Eng 12:83–90PubMedCrossRef
140.
Kaihara S, Borenstein J, Koka R et al (2000) Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng 6:105–117PubMedCrossRef
141.
Allen JW, Khetani SR, Bhatia SN (2005) In vitro zonation and toxicity in a hepatocyte bioreactor. Toxicol Sci 84:110–119PubMedCrossRef
142.
Gebhardt R, Hengstler JG, Muller D et al (2003) New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab Rev 35:145–213PubMedCrossRef
143.
Hong KU, Reynolds SD, Giangreco A et al (2001) Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol 24:671–681PubMed
144.
Kim CF, Jackson EL, Woolfenden AE (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121:823–835PubMedCrossRef
145.
Coraux C, Nawrocki-Raby B, Hinnrasky J et al (2005) Embryonic stem cells generate airway epithelial tissue. Am J Respir Cell Mol Biol 32:87–92PubMedCrossRef
146.
Van Vranken BE, Romanska HM, Polak JM (2005) Coculture of embryonic stem cells with pulmonary mesenchyme: a microenvironment that promotes differentiation of pulmonary epithelium. Tissue Eng 11:1177–1187PubMedCrossRef
147.
Saxena AK, Marler J, Benvenuto M (1999) Skeletal muscle tissue engineering using isolated myoblasts on synthetic biodegradable polymers: preliminary studies. Tissue Eng 5:525–532PubMedCrossRef
148.
Saxena AK, Willital GH, Vacanti JP (2001) Vascularized three-dimensional skeletal muscle tissue-engineering. Biomed Mater Eng 11:275–281PubMed
149.
Tsang VL, Bhatia SN (2004) Three-dimensional tissue fabrication. Adv Drug Deliv Rev 56:1635–1647PubMedCrossRef
150.
Costa KD, Lee EJ, Holmes JW (2003) Creating alignment and anisotropy in engineered heart tissue: Role of boundary conditions in a model three-dimensional culture system. Tissue Eng 9:567–577PubMedCrossRef
151.
Girton TS, Barocas VH, Tranquillo RT (2002) Confined compression of a tissue-equivalent: collagen fibril and cell alignment in response to anisotropic strain. J Biomech Eng 124:568–575PubMedCrossRef
152.
Taylor NA, Wilkinson JG (1986) Exercise-induced skeletal muscle growth. Hypertrophy or hyperplasia? Sports Med 3:190–200PubMedCrossRef
153.
Vandenburgh HH, Karlisch P (1989) Longitudinal growth of skeletal myotubes in vitro in a new horizontal mechanical cell stimulator. In Vitro Cell Dev Biol 25:607–616PubMedCrossRef
154.
Cheema U, Yang SY, Mudera V (2003) 3-D in vitro model of early skeletal muscle development. Cell Motil Cytoskeleton 54:226–236PubMedCrossRef
155.
Tatsumi R, Sheehan SM, Iwasaki H (2001) Mechanical stretch induces activation of skeletal muscle satellite cells in vitro. Exp Cell Res 267:107–114PubMedCrossRef
156.
Darr KC, Schultz E (1987) Exercise-induced satellite cell activation in growing and mature skeletal muscle. J Appl Physiol 63:1816–1821PubMed
157.
Kook SH, Lee HJ, Chung WT et al (2008) Cyclic mechanical stretch stimulates the proliferation of C2C12 myoblasts and inhibits their differentiation via prolonged activation of p38 MAPK. Mol Cells 25(4):479–486PubMed
158.
Otis JS, Burkholder TJ, Pavlath GK (2005) Stretch-induced myoblast proliferation is dependent on the COX2 pathway. Exp Cell Res 310:417–425PubMedCrossRef
159.
Fujita H, Nedachi T, Kanzaki M (2007) Accelerated de novo sarcomere assembly by electric pulse stimulation in C2C12 myotubes. Exp Cell Res 313:1853–1865PubMedCrossRef
160.
De Deyne PG (2000) Formation of sarcomeres in developing myotubes: Role of mechanical stretch and contractile activation. Am J Physiol Cell Physiol 279:C1801–C1811PubMed
161.
Larkin LM, Van der Meulen JH, Dennis RG (2006) Functional evaluation of nerve-skeletal muscle constructs engineered in vitro. In Vitro Cell Dev Biol Anim 42:75–82PubMedCrossRef
162.
Dhawan V, Lytle IF, Dow DE (2007) Neurotization improves contractile forces of tissue-engineered skeletal muscle. Tissue Eng 13:2813–2821PubMedCrossRef
Metadaten
Titel
Tissue engineering and regenerative medicine research perspectives for pediatric surgery
verfasst von
Amulya K. Saxena
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Pediatric Surgery International / Ausgabe 6/2010
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-010-2591-8

Weitere Artikel der Ausgabe 6/2010

Pediatric Surgery International 6/2010 Zur Ausgabe

Original Article

Transanal one-stage endorectal pull-through for Hirschsprung disease: experiences with 51 newborn patients

Original Article

Interval between clinical presentation of necrotizing enterocolitis and bowel perforation in neonates

Original Article

The distal level of normally innervated bowel in long segment colonic Hirschsprung’s disease

Original Article

Overnight urethral stenting after tubularized incised plate urethroplasty for distal hypospadias

Original Article

Effect of intraperitoneal erythropoietin on the degree of mucosal damage of left colon flaps in rats

Original Article

The testicular descent in the rat: a scanning electron microscopic study

Neu im Fachgebiet Pädiatrie

22.04.2024 | Fehlsichtigkeit | Nachrichten

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

18.04.2024 | Spinale Muskelatrophien | Nachrichten

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

16.04.2024 | Störungen der Geschlechtsidentität | Nachrichten

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert
weitere anzeigen

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen